Entera Bio (ENTX) Expected to Announce Quarterly Earnings on Friday

Entera Bio (NASDAQ:ENTX) is anticipated to post its quarterly earnings results before the market opens on Friday, March 14th. Analysts expect Entera Bio to post earnings of ($0.08) per share and revenue of $0.04 million for the quarter.

Entera Bio Price Performance

ENTX opened at $1.98 on Thursday. The firm has a market cap of $70.85 million, a PE ratio of -7.62 and a beta of 1.62. The stock has a 50-day moving average price of $2.27 and a 200-day moving average price of $2.01. Entera Bio has a 1 year low of $1.30 and a 1 year high of $3.35.

Entera Bio Company Profile

Entera Bio Ltd., a clinical-stage company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of stress fractures.